The Value of PET Imaging Targeting Granzyme B in Predicting Efficacy and Prognosis in T-NK Cell Lymphoma
The study on the value of PET imaging targeting granzyme B in predicting the efficacy and prognosis of T-NK cell lymphoma.
T-NK Cell Lymphoma
Standardized uptake value (SUV), SUV of 68Ga-grazytracer uptake on PET/CT images for tumor lesions, Baseline and 7-10 days after treatment
Progress free suivival, Progress free suivival, 3 years|Overall survival, Overall survival, 3 years
The investigators will number all participants, create a medical record file, and record their basic information (gender, age) as well as contact information and medical history information. All participants will undergo 68Ga-grazytracer PET at baseline and after one course of immunotherapy.